Assets
Technology
Leadership
News
Investor Relations
More
Arbitration Confirms NovelStem Joint Venture’s Rights to Exploit‘Tom Clancy’s Net Force’ Franchise
NovelStem, Focused on a Patented Genetic Platform Technology for Anti-Cancer Therapies, Reports...
NovelStem’s Affiliate NewStem Announced New Collaboration to Validate its Software Diagnostic Device
NovelStem Reports Third Quarter Results on Form 10-Q
NovelStem Now an SEC-Reporting Company, Secures Commitment for up to $600K in Bridge Funding...
NovelStem Announces FDA Pre-Submission and EMA In Vitro Diagnostic Device Filing for Revolutionary
NovelStem Reviews Efforts to Maximize Value from Legacy Entertainment Asset
NovelStem Files Preliminary Financial Statements in Compliance with SEC Rule 15c2-11...
NovelStem Announces NewStem, Ltd. was Selected by Illumina for its Global Illumina Accelerator
NovelStem Increases NewStem Ownership to 33% as NewStem Prepares for First-Half 2021 FDA Filing...
NovelStem Announces New Research Collaborations for Stem-Cell Technology Platform...
NovelStem Provides Shareholder Update
Hollywood Media Changes Name and Stock Symbol to Novel Stem International Corp. and “NSTM”...
Hollywood Media Completes Transformational Investment in NewStem, Israel-Based Developer...